Beta Amyloid Peptide: Beta Amyloid Peptide: Research Paper : Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease

Beta Amyloid Peptide: Research Paper : Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease

Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease

Abstract

Background: Alzheimer's disease (AD) is an adult-onset mental disorder with aging as a major risk factor. Early and progressive degeneration of basal forebrain cholinergic neurons (BFCNs) contributes substantially to cognitive impairments of AD. An aging-relevant cell model of BFCNs will critically help understand AD and identify potential therapeutics. Recent studies demonstrate that induced neurons directly reprogrammed from adult human skin fibroblasts retain aging-associated features. However, human induced BFCNs (hiBFCNs) have yet to be achieved.

Methods: We examined a reprogramming procedure for the generation of aging-relevant hiBFCNs through virus-mediated expression of fate-determining transcription factors. Skin fibroblasts were obtained from healthy young persons, healthy adults and sporadic AD patients. Properties of the induced neurons were examined by immunocytochemistry, qRT-PCR, western blotting, and electrophysiology.

Results: We established a protocol for efficient generation of hiBFCNs from adult human skin fibroblasts. They show electrophysiological properties of mature neurons and express BFCN-specific markers, such as CHAT, p75NTR, ISL1, and VACHT. As a proof-of-concept, our preliminary results further reveal that hiBFCNs from sporadic AD patients exhibit time-dependent TAU hyperphosphorylation in the soma and dysfunctional nucleocytoplasmic transport activities.

Conclusions: Aging-relevant BFCNs can be directly reprogrammed from human skin fibroblasts of healthy adults and sporadic AD patients. They show promises as an aging-relevant cell model for understanding AD pathology and may be employed for therapeutics identification for AD.

Keywords: Aging; Alzheimer's disease; BFCNs; Fibroblasts; Nucleocytoplasmic transport; Reprogramming; TAU hyperphosphorylation.

Conflict of interest statement

The authors do not have competing interests in the manuscript.

This article originally appeared in the "https://pubmed.ncbi.nlm.nih.gov/33087140/" and has their copyrights. We do not claim copyright on the content. This information is for research purposes only. This Blog is made available by publishers for educational purposes only as well as to give you general information and a general understanding , not to provide specific advice. By using this blog site you understand that there is no client relationship between you and the Blog publisher. The Blog should not be used as a substitute for competent research advice.  




No comments:

Post a Comment

The secret of Eta Black by Ananya Sharma

The secret of Eta Black by Ananya Sharma  A man sitting behind the bars named Eta black has no clue what is happening with him. He was searc...

Blog Archive

Pageviews

Beta Amyloid Research